MEKCHOL Tablets 30's

• Adults: Take orally according to the dosage instructions printed on the current manufacturer-approved product label or as directed by a qualified homoeopathic practitioner.
• Mektum's official MEKCHOL product page does not specify a numerical adult tablet dose or daily administration frequency.
• Do not assume a dose of one tablet two or three times daily based on other Mektum products.
• Take the tablets with water if instructed on the current product packaging.
• Do not assume that the tablets should be swallowed whole, chewed, or dissolved under the tongue without verifying the manufacturer's administration instructions.
• Follow the recommended frequency and treatment duration stated on the physical container.
• Do not exceed the recommended dosage.
• Children and adolescents: Use only after specialist medical advice. Suspected inherited or familial high cholesterol requires appropriate medical assessment.
• Pregnancy and breastfeeding: Avoid use unless a qualified healthcare professional has reviewed the complete formulation and specifically advised otherwise.
• Older adults: Consult a healthcare professional before use, particularly when taking multiple cardiovascular medicines.
• People with high cholesterol: Continue prescribed lipid-lowering medicines and recommended monitoring unless the treating clinician advises otherwise.
• People with heart disease: Obtain medical advice before use because the formulation includes Crataegus and other botanically derived preparations with unverified concentrations.
• People taking anticoagulants or antiplatelet medicines: Seek professional advice because Allium Sativum may have clinically relevant effects on bleeding risk at certain doses.
• People with kidney or liver disease: Consult a healthcare professional before use because the complete concentrations of Colchicum and Podophyllum are unknown.
• People with diabetes: Continue prescribed treatment and monitor cardiovascular risk factors according to professional advice.
• People with bleeding disorders: Avoid unsupervised use.
• Individuals taking statins, blood-pressure medicines, digoxin, diuretics, anticoagulants, antiplatelet medicines, or other prescription treatments should have possible interactions reviewed by a healthcare professional.
• Avoid combining MEKCHOL with multiple herbal cardiovascular supplements without reviewing their ingredients.
• Do not use prolonged or repeated courses without professional medical guidance.
• Discontinue use and seek medical assessment if unusual gastrointestinal symptoms, dizziness, palpitations, weakness, bleeding, or suspected adverse reactions occur.

Mektum's official product listing instructs users to take MEKCHOL according to the product label or a qualified homoeopathic practitioner's directions. It does not provide an exact adult dosage, paediatric regimen, administration method, meal timing, or maximum treatment duration.

These details should be verified against the current physical 30-tablet container, carton, or manufacturer-approved leaflet before publication.

Because the formulation includes Colchicum and Podophyllum, both of which originate from potentially toxic botanical source materials, its exact potencies and concentrations are particularly important for safe dosing.

Usage Information

MEKCHOL Tablets may be incorporated into complementary homoeopathic care for individuals seeking traditional cardiovascular and cholesterol-related wellness support. They are intended for oral use according to the manufacturer's directions and should be accompanied by a heart-healthy diet, suitable physical activity, regular cardiovascular risk assessment, and appropriate medical treatment.

The preparation should not be expected to reliably lower LDL cholesterol, reduce triglycerides, remove arterial plaque, reverse atherosclerosis, or prevent heart attacks and strokes. It must not replace prescribed statins, other lipid-lowering medicines, blood-pressure treatments, or established cardiovascular care.

High cholesterol is frequently asymptomatic. A person may have significantly elevated LDL cholesterol without experiencing pain, dizziness, breathlessness, or other obvious symptoms.

Regular lipid testing is therefore important for individuals with recognised cardiovascular risk factors.

A lipid profile commonly measures total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. Additional investigations may be appropriate depending on a person's medical history and cardiovascular risk.

High LDL cholesterol is an important modifiable cardiovascular risk factor. Treatment decisions depend on cholesterol levels and other factors, including age, blood pressure, diabetes, smoking, chronic kidney disease, family history, and whether cardiovascular disease is already present.

Heart-healthy nutrition can contribute to improved lipid management. Dietary approaches may include reducing saturated fats, avoiding industrial trans fats, and choosing suitable unsaturated fats.

Foods such as vegetables, fruits, whole grains, legumes, nuts, seeds, fish, and appropriate plant oils may form part of a balanced cardiovascular diet.

Soluble fibre from foods such as oats, barley, beans, and certain fruits can help with cholesterol management as part of a suitable eating pattern.

Regular physical activity supports cardiovascular fitness and may contribute to improved blood pressure, metabolic health, and overall wellbeing. Exercise programmes should be adapted to individual fitness levels and medical conditions.

Smoking cessation is particularly important because smoking increases cardiovascular risk. Individuals who smoke may benefit from professional cessation support.

Maintaining appropriate blood pressure and blood glucose levels also contributes to cardiovascular health. Patients with hypertension or diabetes should continue their prescribed treatment and monitoring.

Statins and other prescribed lipid-lowering medicines have an established role in reducing cardiovascular risk in appropriately selected patients. Their use depends on individual risk assessment and clinical guidance.

People who have previously experienced a heart attack, stroke, or other atherosclerotic cardiovascular event may require long-term lipid-lowering therapy as part of secondary prevention.

Do not stop or reduce prescribed cholesterol-lowering medicines when starting MEKCHOL.

Some people have inherited disorders that cause unusually high cholesterol, such as familial hypercholesterolaemia. These conditions often require specialist assessment and may require treatment from a relatively young age.

MEKCHOL has not been shown to correct inherited cholesterol disorders or prevent their complications.

Medicine interactions require particular attention. Patients taking anticoagulants or antiplatelet medicines should have the Allium Sativum component reviewed, while those taking cardiovascular medicines should discuss the Crataegus component with their clinician.

The inclusion of Colchicum and Podophyllum introduces additional uncertainty because their potencies and active-compound concentrations have not been published.

Individuals with liver or kidney disease should obtain professional advice before use. These conditions may affect the suitability of medicines and certain botanical preparations.

Patients should not combine MEKCHOL with multiple herbal cholesterol supplements or other unverified homoeopathic products without a review of their ingredients.

The manufacturer's references to cholesterol balance, circulation, and prevention of fatty deposits should be interpreted as traditional or promotional descriptions rather than evidence of demonstrated cardiovascular protection.

Seek medical advice for persistently elevated cholesterol, uncontrolled blood pressure, recurring chest discomfort, unexplained breathlessness, dizziness, leg swelling, or reduced exercise tolerance.

Severe chest pain or pressure, especially when spreading to the arm, jaw, neck, back, or shoulder, requires emergency medical attention. Associated symptoms may include sweating, nausea, breathlessness, or fainting.

Sudden facial drooping, weakness or numbness on one side of the body, difficulty speaking, sudden loss of vision, or sudden severe neurological symptoms also require emergency medical care, as they may indicate a stroke.

If severe abdominal pain, repeated vomiting, diarrhoea, marked weakness, or unusual neurological symptoms develop after taking MEKCHOL, stop use and seek urgent medical advice. These symptoms warrant particular caution because the formula contains Colchicum and Podophyllum with unverified concentrations.

MEKCHOL Tablets should not be used to delay diagnosis or treatment of high cholesterol, atherosclerosis, coronary artery disease, hypertension, stroke, peripheral arterial disease, or other underlying cardiovascular conditions.

Storage Instructions

Store MEKCHOL Tablets tightly closed in their original 30-tablet container in a cool, dry place away from direct sunlight, excessive heat, moisture, and strong odours. Follow any specific storage temperature requirements printed on the current manufacturer-approved packaging. Protect the tablets from humidity and avoid storing them in bathrooms or other damp environments where moisture may affect their physical stability. Keep the container securely out of the sight and reach of children, particularly because the formulation contains Colchicum and Podophyllum, whose botanical source materials can be toxic and whose finished-product potencies and concentrations have not been verified. Do not use after the expiry date or if the container is damaged, the seal is compromised, or the tablets show unusual changes in colour, appearance, texture, or odour. Handle the tablets with clean, dry hands, avoid introducing moisture into the container, and close it securely after each use. Retain the original container, carton, and manufacturer-approved leaflet for confirmation of the exact active-ingredient identities, homoeopathic potencies, quantitative composition, colchicine- and podophyllotoxin-related constituent concentrations, tablet excipients, sugar and allergen status, approved dosage instructions, storage requirements, precautions, and market-specific product information.